About Us
Catalace is a suite of healthcare software applications. Catalace Platform helps oncologists make correct cancer treatment decisions, predicts the tolerance of drugs, reduces unnecessary surgeries, and improves patient health outcomes. Catalace TrialCell helps doctors, researchers, and students by creating on-demand summaries of medical journal articles.
Our software uses the following to generate conclusions:
- Computationally efficient AI algorithms
- Intelligent systems to parse through data
- Weighted algorithms to synthesize multiple data formats and generate clinical outputs and next steps
Currently, Catalace Platform and Catalace TrialCell are available.
Learn MoreCatalace Platform
Catalace Platform creates personalized cancer treatment plans for patients based on pathology biopsy report, blood panels, genomic information, and patient history. We combine artificial intelligence with precision medicine to generate clinical conclusions through three steps:
2. Let Our AI and Precision Medicine Algorithms Synthesize
We perform fast and efficient reading and compiling of all inputs
3. We Give You A Treatment Plan
Based on a patient's unique characteristics and NCCN guideines, we provide a therapy and management plan
Catalace TrialCell
Catalace TrialCell creates detailed summaries of medical journal articles to help doctors, researchers, and students stay up to date on the latest medical research
Download Catalace TrialCell on the Google Play Store and Apple App Store soon!
Team
Our team is composed of scientists with experience at various levels of healthcare who are dedicated to creating technology-driven medical solutions
Dana Joseph, MPH
Chief Executive Officer (CEO)
Newlyn Joseph, MD, MS
Chief Technical Officer (CTO)
Adrian Joseph
Lead DeveloperContact Us
Any questions?
You can use the form to the right or reach out to any of members of the current team through LinkedIn or via email.